Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus

Phase 1 ◽

Dose Finding ◽

Obese Patients ◽

Finding Study ◽

Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2012.11.005 ◽

2013 ◽

Vol 27 (3) ◽

pp. 268-273 ◽

Cited By ~ 59

Author(s):

Vivian A. Fonseca ◽

Ele Ferrannini ◽

John P. Wilding ◽

Wim Wilpshaar ◽

Perminder Dhanjal ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Dose Finding ◽

Multiple Doses ◽

Finding Study ◽

A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus

Current Medical Research and Opinion ◽

10.1185/03007995.2014.896327 ◽

2014 ◽

Vol 30 (6) ◽

pp. 1095-1106 ◽

Cited By ~ 23

Author(s):

Yutaka Seino ◽

Nobuya Inagaki ◽

Hajime Miyahara ◽

Inaha Okuda ◽

Mark Bush ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Dose Finding ◽

Finding Study ◽

Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study

Current Medical Research and Opinion ◽

10.1185/03007995.2014.909390 ◽

2014 ◽

Vol 30 (7) ◽

pp. 1231-1244 ◽

Cited By ~ 30

Author(s):

Yutaka Seino ◽

Takashi Sasaki ◽

Atsushi Fukatsu ◽

Michito Ubukata ◽

Soichi Sakai ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Ii Study ◽

Japanese Patients ◽

Dose Finding ◽

Double Blind ◽

Double Blind Placebo ◽

Finding Study ◽

Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus

Endocrine Abstracts ◽

10.1530/endoabs.63.p122 ◽

2019 ◽

Author(s):

Maram M Aboromia ◽

Hesham Elgayar ◽

Nesma Aly ◽

Mostafa Hussein

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Lipid Profile ◽

Obese Patients ◽

Newly Diagnosed ◽

Glycemic Status ◽

Ginger Powder

Real world data of Type 2 Diabetes Mellitus (T2DM) obese patients using another GLP1 receptor agonist (GLP1–RA) and switching to Semaglutide in Spain

Endocrine Abstracts ◽

10.1530/endoabs.70.ep197 ◽

2020 ◽

Author(s):

Jersy Cardenas ◽

Gomez Nancy Sanchez ◽

Sierra Poyatos Roberto Miguel ◽

Luca Bogdana Luiza ◽

Mostoles Naiara Modroño ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Real World ◽

Receptor Agonist ◽

Obese Patients ◽

Real World Data ◽

World Data

Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

Case Medical Research ◽

10.31525/ct1-nct04075110 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Adjuvant Therapy ◽

Obese Patients ◽

Safety And Efficacy

Bariatric surgery versus medical treatment in mildly obese patients with type 2 diabetes mellitus in Japan: propensity score‐matched analysis on real‐world data

Journal of Diabetes Investigation ◽

10.1111/jdi.13631 ◽

2021 ◽

Author(s):

Yosuke Seki ◽

Kazunori Kasama ◽

Renzo Yokoyama ◽

Akihiro Maki ◽

Hideharu Shimizu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Bariatric Surgery ◽

Propensity Score ◽

Medical Treatment ◽

Real World ◽

Obese Patients ◽

Real World Data

Association of new obesity indices: visceral adiposity index and body adiposity index, with metabolic syndrome parameters in obese patients with or without type 2 diabetes mellitus

The Egyptian Journal of Internal Medicine ◽

10.1186/s43162-020-00030-z ◽

2021 ◽

Vol 33 (1) ◽

Author(s):

Mahmood Dhahir Al-Mendalawi

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Metabolic Syndrome ◽

Visceral Adiposity Index ◽

Obese Patients ◽

Adiposity Index ◽

Body Adiposity ◽

Obesity Indices

Surgical treatment of nonseverely obese patients with type 2 diabetes mellitus: sleeve gastrectomy with ileal transposition (SGIT) is the same as the neuroendocrine brake (NEB) procedure or ileal interposition associated with sleeve gastrectomy (II-SG), but ileal interposition with diverted sleeve gastrectomy (II-DSG) is the same as duodenal switch

Surgical Endoscopy ◽

10.1007/s00464-010-1221-9 ◽

2010 ◽

Vol 25 (2) ◽

pp. 655-656 ◽

Cited By ~ 10

Author(s):

Michel Gagner

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Sleeve Gastrectomy ◽

Surgical Treatment ◽

Duodenal Switch ◽

Obese Patients ◽

Ileal Transposition ◽

Ileal Interposition

Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus

Diabetic Medicine ◽

10.1046/j.1464-5491.2000.00367.x ◽

2000 ◽

Vol 17 (10) ◽

pp. 713-719 ◽

Cited By ~ 70

Author(s):

E. Mannucci ◽

A. Ognibene ◽

F. Cremasco ◽

G. Bardini ◽

A. Mencucci ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Obese Patients ◽

Glucagon Like Peptide